Nephron Pharmaceuticals Recognized in 2025 RXinsider Pharmacy500

West Columbia, SC — Nephron Pharmaceuticals has been named one of the most influential companies in the pharmacy supply chain by RxInsider, earning a place on the 2025 Pharmacy500 list. This national recognition honors 500 organizations that are making a meaningful impact on dispensing pharmacies across the United States.

“We are proud to be recognized by RxInsider for the second year in a row,” said Nephron CEO Lou Kennedy. “This honor reflects the dedication of our entire team to ensuring access to safe, effective medications that support pharmacies and the patients they serve.”

The Pharmacy500 acknowledges companies demonstrating leadership in pharmaceutical manufacturing, distribution, technology, and support services. Nephron was selected for its continued contributions to healthcare through:

• Operating one of the largest blow-fill-seal (BFS) facilities in the world
• Manufacturing a broad portfolio of respiratory, injectable, and ophthalmic medications
• Delivering 503B outsourcing services to hospitals and surgery centers nationwide
• Actively addressing drug shortages and strengthening the domestic pharmaceutical supply chain

From its 840,000-square-foot advanced manufacturing campus in Lexington County, South Carolina, Nephron remains committed to building a stronger, more resilient pharmacy infrastructure across the nation.

To learn more about Nephron’s capabilities and impact, visit www.nephronpharm.com.